Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 17-Sep-21 4:49 PM View:  | Alimera Sciences Inc (ALIM) | 17-Sep-21 | Acquisition (other) | 215 | -- | -- | 192% 0.11K to 0.33K | |
| 06-Nov-18 4:16 PM View: | Dicerna Pharmaceuticals Inc (DRNA) | 06-Nov-18 | Market Sale | 104,328 | $13.19 | $1,376,510.00 | (4%) 2.71M to 2.61M | (188%) |
| 06-Nov-18 4:16 PM View: | Dicerna Pharmaceuticals Inc (DRNA) | 05-Nov-18 | Market Sale | 39,901 | $12.98 | $517,915.00 | (1%) 2.75M to 2.71M | (192%) |
| 06-Nov-18 4:16 PM View: | Dicerna Pharmaceuticals Inc (DRNA) | 02-Nov-18 | Market Sale | 190,771 | $13.47 | $2,569,690.00 | (6%) 2.94M to 2.75M | (182%) |
| 01-Nov-18 6:08 PM View: | Dicerna Pharmaceuticals Inc (DRNA) | 01-Nov-18 | Market Sale | 189,575 | $13.37 | $2,534,620.00 | (6%) 3.13M to 2.94M | (184%) |
| 01-Nov-18 6:08 PM View: | Dicerna Pharmaceuticals Inc (DRNA) | 31-Oct-18 | Market Sale | 129,629 | $13.60 | $1,762,950.00 | (4%) 3.26M to 3.13M | (179%) |
| 01-Nov-18 6:08 PM View: | Dicerna Pharmaceuticals Inc (DRNA) | 30-Oct-18 | Market Sale | 245,096 | $13.92 | $3,410,620.00 | (7%) 3.51M to 3.26M | (173%) |
| 11-Jun-18 4:12 PM View: | Dicerna Pharmaceuticals Inc (DRNA) | 07-Jun-18 | Payment of Exercise | 10,271 | $14.45 | $148,416.00 | (< 1%) 3.52M to 3.51M | (163%) |
| 11-Jun-18 4:12 PM View: | Dicerna Pharmaceuticals Inc (DRNA) | 07-Jun-18 | Option Exercise | 21,197 | $7.00 | $148,379.00 | < 1% 3.49M to 3.52M | |
| 17-Jul-15 4:39 PM View: | Alimera Sciences Inc (ALIM) | 16-Jul-15 | Acquisition (other) | 1,692 | -- | -- | 100% 0 to 1.69K | |
| 21-Mar-14 7:39 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 19-Mar-14 | Disposition | 3,050,920 | $14.00 | $42,712,900.00 | (100%) 3.05M to 0 | < 1% |
| 17-Mar-14 2:51 PM View: | Achaogen, Inc. (AKAO) | 17-Mar-14 | Conversion Duplicate | 2,020,940 | -- | -- | 100% 0 to 2.02M | |
| 04-Feb-14 4:04 PM View: | Dicerna Pharmaceuticals Inc (DRNA) | 04-Feb-14 | Conversion Duplicate | 1,765,710 | -- | -- | 100% 0 to 1.77M | |
| 19-Nov-13 6:39 PM View: | Tandem Diabetes Care Inc (TNDM) | 19-Nov-13 | Conversion Duplicate | 3,243,450 | -- | -- | 100% 0 to 3.24M | |
| 19-Nov-13 6:48 PM View: | Tandem Diabetes Care Inc (TNDM) | 19-Nov-13 | Conversion Duplicate | 3,243,450 | -- | -- | 100% 0 to 3.24M | |
| 04-Nov-13 4:06 PM View: | Veracyte, Inc. (VCYT) | 04-Nov-13 | Conversion | 3,086,020 | -- | -- | 100% 0 to 3.09M | |
| 30-Sep-13 5:44 PM View: | Evoke Pharma Inc (EVOK) | 30-Sep-13 | Conversion Duplicate | 1,133,330 | -- | -- | 21587% 5.25K to 1.14M | |
| 16-Jul-13 8:30 PM View: | Tranzyme, Inc. (OCRX) | 15-Jul-13 | Purchase Duplicate | 1,327,490 | $6.03 | $7,999,990.00 | 81% 1.63M to 2.96M | |
| 02-Jul-13 4:51 PM View: | Esperion Therapeutics, Inc. (ESPR) | 01-Jul-13 | Conversion Duplicate | 1,816,470 | -- | -- | 100% 0 to 1.82M | |
| 02-Jul-13 4:51 PM View: | Esperion Therapeutics, Inc. (ESPR) | 01-Jul-13 | Purchase Duplicate | 285,714 | $14.00 | $4,000,000.00 | 16% 1.82M to 2.1M | |
| 18-Jan-13 12:27 PM View: | Achillion Pharmaceuticals, ... (ACHN) | 18-Jan-13 | Acquisition (other) Duplicate | 66,462 | -- | -- | < 1% 6.95M to 7.02M | |
| 18-Jan-13 12:27 PM View: | Achillion Pharmaceuticals, ... (ACHN) | 18-Jan-13 | Disposition (other) Duplicate | 1,000,000 | -- | -- | (14%) 7.02M to 6.02M | |
| 24-Jul-12 12:13 PM View: | Durata Therapeutics, Inc. (DRTX) | 24-Jul-12 | Conversion Duplicate | 2,244,120 | -- | -- | 100% 0 to 2.24M | |
| 24-Jul-12 12:13 PM View: | Durata Therapeutics, Inc. (DRTX) | 24-Jul-12 | Purchase Duplicate | 784,313 | $9.00 | $7,058,820.00 | 35% 2.24M to 3.03M | |
| 04-Jun-12 3:05 PM View: | Achillion Pharmaceuticals, ... (ACHN) | 31-May-12 | Acquisition (other) Duplicate | 93,434 | -- | -- | 1% 8.06M to 8.15M | |
| 04-Jun-12 3:05 PM View: | Achillion Pharmaceuticals, ... (ACHN) | 31-May-12 | Disposition (other) Duplicate | 1,200,000 | -- | -- | (15%) 8.15M to 6.95M | |
| 22-Dec-11 5:28 PM View: | Orexigen Therapeutics, Inc. (OREXQ) | 22-Dec-11 | Private Purchase Duplicate | 469,147 | $1.45 | $680,263.00 | 18% 2.55M to 3.02M | |
| 21-Nov-11 8:54 PM View: | Clovis Oncology, Inc. (CLVS) | 21-Nov-11 | Conversion Duplicate | 2,110,270 | -- | -- | 100% 0 to 2.11M | |
| 21-Nov-11 8:54 PM View: | Clovis Oncology, Inc. (CLVS) | 21-Nov-11 | Market Purchase Duplicate | 931,683 | $13.00 | $12,111,900.00 | 44% 2.11M to 3.04M | (62%) |
| 20-Sep-11 3:13 PM View: | Zogenix, Inc. (ZGNX) | 16-Sep-11 | Market Purchase Duplicate | 3,500,000 | $2.00 | $7,000,000.00 | 53% 6.59M to 10.09M | 33% |
| 01-Dec-10 10:37 AM View: | Zogenix, Inc. (ZGNX) | 29-Nov-10 | Conversion | 4,242,590 | -- | -- | 100% 0 to 4.24M | |
| 01-Dec-10 10:37 AM View: | Zogenix, Inc. (ZGNX) | 29-Nov-10 | Purchase Duplicate | 2,350,000 | $4.00 | $9,400,000.00 | 55% 4.24M to 6.59M | |
| 08-Oct-10 4:50 PM View: | Achillion Pharmaceuticals, ... (ACHN) | 06-Oct-10 | Acquisition (other) Duplicate | 25,000 | -- | -- | 100% 0 to 25.0K | |
| 30-Mar-10 11:03 AM View: | Vanda Pharmaceuticals, Inc. (VNDA) | 26-Mar-10 | Acquisition (other) | 7,276 | -- | -- | 100% 0 to 7.28K | |
| 21-Dec-09 9:47 AM View: | Orexigen Therapeutics, Inc. (OREXQ) | 18-Dec-09 | Market Purchase Duplicate | 38,100 | $7.50 | $285,750.00 | 2% 2.51M to 2.55M | (96%) |
| 21-Dec-09 9:47 AM View: | Orexigen Therapeutics, Inc. (OREXQ) | 17-Dec-09 | Market Purchase Duplicate | 100,000 | $7.55 | $755,000.00 | 4% 2.41M to 2.51M | (96%) |
| 25-Nov-09 3:20 PM View: | Orexigen Therapeutics, Inc. (OREXQ) | 24-Nov-09 | Market Purchase Duplicate | 50,000 | $6.75 | $337,500.00 | 2% 2.36M to 2.41M | (95%) |
| 24-Nov-09 5:56 PM View: | Orexigen Therapeutics, Inc. (OREXQ) | 23-Nov-09 | Market Purchase Duplicate | 150,000 | $6.93 | $1,039,500.00 | 7% 2.21M to 2.36M | (95%) |
| 24-Nov-09 5:56 PM View: | Orexigen Therapeutics, Inc. (OREXQ) | 20-Nov-09 | Market Purchase Duplicate | 250,000 | $6.93 | $1,732,500.00 | 13% 1.96M to 2.21M | (95%) |
| 16-Nov-09 2:44 PM View: | Orexigen Therapeutics, Inc. (OREXQ) | 12-Nov-09 | Market Purchase Duplicate | 62,000 | $6.90 | $427,800.00 | 3% 1.9M to 1.96M | (95%) |
| 12-Nov-09 4:41 PM View: | Orexigen Therapeutics, Inc. (OREXQ) | 11-Nov-09 | Market Purchase Duplicate | 53,600 | $6.93 | $371,448.00 | 3% 1.85M to 1.9M | (95%) |
| 12-Nov-09 4:41 PM View: | Orexigen Therapeutics, Inc. (OREXQ) | 10-Nov-09 | Market Purchase Duplicate | 84,400 | $6.93 | $584,892.00 | 5% 1.76M to 1.85M | (95%) |
| 19-Aug-09 4:55 PM View: | Orexigen Therapeutics, Inc. (OREXQ) | 18-Aug-09 | Market Purchase Duplicate | 13,784 | $7.73 | $106,550.00 | < 1% 1.75M to 1.76M | (96%) |
| 18-Aug-09 8:14 PM View: | Orexigen Therapeutics, Inc. (OREXQ) | 17-Aug-09 | Market Purchase | 63,201 | $7.64 | $482,856.00 | 4% 1.68M to 1.75M | (96%) |
| 18-Aug-09 8:14 PM View: | Orexigen Therapeutics, Inc. (OREXQ) | 14-Aug-09 | Market Purchase | 26,225 | $8.00 | $209,800.00 | 2% 1.66M to 1.68M | (96%) |
| 14-Aug-09 6:55 PM View: | Orexigen Therapeutics, Inc. (OREXQ) | 13-Aug-09 | Market Purchase Duplicate | 13,000 | $7.85 | $102,050.00 | < 1% 1.64M to 1.66M | (96%) |
| 14-Aug-09 6:55 PM View: | Orexigen Therapeutics, Inc. (OREXQ) | 12-Aug-09 | Market Purchase Duplicate | 400,000 | $8.00 | $3,200,000.00 | 32% 1.24M to 1.64M | (96%) |
| 13-Aug-09 3:49 PM View: | Orexigen Therapeutics, Inc. (OREXQ) | 11-Aug-09 | Market Purchase Duplicate | 104,300 | $7.60 | $792,680.00 | 9% 1.14M to 1.24M | (96%) |
| 24-Jul-09 4:22 PM View: | Orexigen Therapeutics, Inc. (OREXQ) | 23-Jul-09 | Market Purchase Duplicate | 650,000 | $7.50 | $4,875,000.00 | 133% 490.3K to 1.14M | (96%) |
| 20-Feb-09 1:47 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 18-Feb-09 | Market Purchase Duplicate | 2,780,670 | $7.13 | $19,826,200.00 | 100% 0 to 2.78M | 4% |